News24 | Aspen gets Canadian nod for generic GLP-1 pen – but flags supplier snag 

​Aspen Pharmacare shares lifted 4% on Monday, after the company announced it had received approval for its generic injectable semaglutide in Canada.   

Leave a Reply

Your email address will not be published. Required fields are marked *